Nestlé Sells Nature's Bounty to Yellow Wood for $1bn: Mainstream Vitamins Now Trade Below One Times Sales

I think the price tells you more here than the brand names do. Nestlé paid 3.1 times sales for Bountiful in 2021. It has now sold the mainstream half for 1.0 billion dollars. Those brands made 1.2 billion dollars of sales in 2025.

The deal landed on 1 September 2026. Nestlé is selling its mainstream vitamins, minerals and supplements business to Yellow Wood Partners. Nestlé calls the group of brands its Holistic Health range. The price is 1.0 billion dollars, or 0.8 billion Swiss francs. It should close by the first half of 2027, once watchdogs clear it.

What is in the box

Seven brands go across. Nature's Bounty, Osteo Bi-Flex, Ester-C, Gard, Nuun, Puritan's Pride and Sisu. The US private label supplements business goes with them. So do the plants, the packing lines, the warehouses and the delivery network.

That last part is the tell. A brand sale does not need a factory attached. This one has one.

Nestlé keeps Solgar and Pure Encapsulations. Those sit at the top of the vitamin aisle and sell on science. Chief executive Philipp Navratil said the mainstream business needs a different approach under its own owner. The sold business trades mostly in the US, with sales in Canada and China too.

The 2021 price and the 2026 price

Nestlé finished buying the core Bountiful brands from KKR in August 2021. It paid 5.75 billion dollars, and that was 3.1 times sales.

The mainstream half is now going at about 0.8 times sales. The two deals are not a clean match. The 2021 buy included Solgar, which Nestlé is keeping. The direction is still hard to miss.

Five years ago a large food group would pay a full price to own a whole aisle. Today it takes a discount to leave the cheap end of it.

Nestlé also sold a private label business

This is the part most reports skip. Nestlé was making own label vitamins for other firms in the US. That business is walking out of the door with the brands.

Own label work is a volume game. It fills a plant and it holds unit costs down. It also caps what you can charge. A group chasing growth in coffee and pet food has little use for it.

Why a carve-out buyer wins this asset

Yellow Wood Partners does one thing well. It buys unloved brands out of large groups and runs them on their own.

It bought Dr Scholl's from Reckitt in 2021. It bought Suave from Unilever. In 2024 its Suave Brands arm bought ChapStick from Haleon for 510 million dollars. ChapStick was its fifth carve-out in four years.

The pattern is simple. Inside Nestlé these brands compete for money against coffee, pet food and infant nutrition. They lose that fight every year. Under a smaller owner they are the whole business.

Where this sits in the wider clear-out

Nestlé grew first half sales 3.6 percent in 2026, once currency and deals are stripped out. Volume and mix added 1.5 percent of that. Price added 2.1 percent.

The same six months brought other moves. Nestlé bought the rest of yfood. It sold Blue Bottle Coffee. It agreed a 50:50 waters and drinks venture with Platinum Equity, named Peranel. Nestlé expects about 2.8 billion Swiss francs of net cash from that in the first half of 2027.

Add the vitamin sale and the shape is clear. Navratil is cutting Nestlé down to four big areas. Coffee, pet care, nutrition, and food and snacks.

What buyers and operators should take from it

The vitamin aisle has split in two. The top end sells on proof and can hold its price. The middle sells on shelf space and deals, and it is now priced like a supply business.

If you own brands in that middle, check what a buyer would really pay. The answer may look closer to 0.8 times sales than to 3 times. If you own the plant behind them, the answer moves again. The plant is what a carve-out buyer wants.

Expect more of these. Large food groups spent a decade buying into health at full prices. They are now handing the volume half to specialists and keeping the part they can defend. The next few sales in this aisle will set the going rate for everyone else.